Jacques HUGON

Citée par

	Toutes	Depuis 2019
Citations	17550	6258
indice h	65	39
indice i10	200	116

1300

650

325

975

1987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202456 133 160 173 165 179 162 184 184 245 202 235 304 295 238 270 300 279 401 355 416 370 385 423 449 499 516 582 674 696 716 824 838 907 1015 1101 1166 1215

Accès public

Tout afficher

49 articles

5 articles

disponibles

non disponibles

Sur la base des exigences liées au financement

Coauteurs

Peter SpencerOregon Health & Science UniversityAdresse e-mail validée de ohsu.edu
Jean-Louis LaplanchePU-PH Université Paris Descartes /Hôpital Lariboisière AP-HP/ Inserm UMR-S 1144Adresse e-mail validée de aphp.fr
Raymond Chuen-Chung ChangProfessor, Laboratory of Neurodegenerative Diseases, The University of Hong KongAdresse e-mail validée de hku.hk
Katell Peoc'hUniversité Paris Diderot; INSERM 1149; Hopital Beaujon & Hopital BichatAdresse e-mail validée de aphp.fr
Wassim ElyamanAssistant Professor of Neurology, Columbia University Medical CenterAdresse e-mail validée de cumc.columbia.edu
Sylvain LehmannProfessor of Biochemistry, Montpellier UniversityAdresse e-mail validée de umontpellier.fr
David WALLONRouen University HospitalAdresse e-mail validée de chu-rouen.fr
Kwok-Fai SoChair Professor, The University of Hong KongAdresse e-mail validée de hku.hk
Eloi MAGNIN (MD, PhD)Regional Memory Centre (CMRR), Department of Neurology, University Hospital of Besançon, FranceAdresse e-mail validée de univ-fcomte.fr
Marion TibleINSERMAdresse e-mail validée de inserm.fr
Delphine BocheUniversity of Southampton, UKAdresse e-mail validée de soton.ac.uk
Frederic BlancPr. MD-PhD HdR, CM2R, pôle de Gériatrie, Unistra, ICube,CNRS, Hôpitaux Universitaires de StrasbourgAdresse e-mail validée de unistra.fr
Man Shan YuNew York University School of MedicineAdresse e-mail validée de nyumc.org
Hugues ChabriatDept Neurology, Hopital Lariboisiere, Université Paris 7, INSERM U1161Adresse e-mail validée de lrb.aphp.fr
Seth LoveUniversity of BristolAdresse e-mail validée de bris.ac.uk
Anindita BoseHarvard Medical School Brigham and Women's HospitalAdresse e-mail validée de bwh.harvard.edu
Christophe HirtzProfessor of Biochemistry, Université MontpellierAdresse e-mail validée de umontpellier.fr
Ulrich DirnaglCenter for Stroke Research, Charite Universitätsmedizin Berlin, GermanyAdresse e-mail validée de charite.de
Pierre-Marie PreuxInserm U1094 IRD U270 INRAE USC1051 EpiMaCT Epidémiologie des Maladies Chroniques en zone TropicaleAdresse e-mail validée de unilim.fr
Harald Hampel, MD, PhD, MA, MScChief Medical Officer, Senior Vice President, Eisai Inc.Adresse e-mail validée de eisai.com

Suivre

Jacques HUGON

professeur Université Paris Diderot AP-HP, Inserm

Adresse e-mail validée de inserm.fr

Neurologie Neurosciences Médecine


Titre Trier par citations Trier par année Trier par titre	Citée par Citée par	Année
A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group G.Bensimon ,L. Lacomblez , V.Meininger New England Journal of Medicine 330 (9), 585-591, 1994	2766*	1994
Guam amyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin PS Spencer, PB Nunn, J Hugon, AC Ludolph, SM Ross, DN Roy, ... Science 237 (4814), 517-522, 1987	1102	1987
Lathyrism: evidence for role of the neuroexcitatory aminoacid BOAA PS Spencer, A Ludolph, MP Dwivedi, DN Roy, J Hugon, HH Schaumburg The Lancet 328 (8515), 1066-1067, 1986	510	1986
Abnormal retinal thickness in patients with mild cognitive impairment and Alzheimer's disease C Paquet, M Boissonnot, F Roger, P Dighiero, R Gil, J Hugon Neuroscience letters 420 (2), 97-99, 2007	463	2007
Phosphorylation of eukaryotic initiation factor-2α (eIF2α) is associated with neuronal degeneration in Alzheimer's disease RCC Chang, AKY Wong, HK Ng, J Hugon Neuroreport 13 (18), 2429-2432, 2002	342	2002
Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum AL Benedet, M Milà-Alomà, A Vrillon, NJ Ashton, TA Pascoal, F Lussier, ... JAMA neurology 78 (12), 1471-1483, 2021	330	2021
High frequency of potentially pathogenic SORL1 mutations in autosomal dominant early-onset Alzheimer disease. WD Pottier C, Hannequin D, Coutant S, Rovelet-Lecrux A Mol Psychiatry. 17 (9), 875-9, 2012	304	2012
mTOR/p70S6k signalling alteration by Aβ exposure as well as in APP‐PS1 transgenic models and in patients with Alzheimer's disease C Lafay‐Chebassier, M Paccalin, G Page, S Barc‐Pain, ... Journal of neurochemistry 94 (1), 215-225, 2005	261	2005
Cell culture evidence for neuronal degeneration in amyotrophic lateral sclerosis being linked to glutamate AMPA/kainate receptors P Couratier, P Sindou, J Hugon, JM Vallat, M Dumas The Lancet 341 (8840), 265-268, 1993	256	1993
CNTF promotes survival of retinal ganglion cells after induction of ocular hypertension in rats: the possible involvement of STAT3 pathway JZ Ji, W Elyaman, HK Yip, VWH Lee, LW Yick, J Hugon, KF So European Journal of Neuroscience 19 (2), 265-272, 2004	253	2004
Increased hypoxic tolerance by chemical inhibition of oxidative phosphorylation:“chemical preconditioning” MW Riepe, F Esclaire, K Kasischke, S Schreiber, H Nakase, O Kempski, ... Journal of Cerebral Blood Flow & Metabolism 17 (3), 257-264, 1997	229	1997
Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex J Hugon, EF Msika, M Queneau, K Farid, C Paquet Journal of Neurology 269 (1), 44-46, 2022	228	2022
mTOR‐dependent signalling in Alzheimer's disease JJ Pei, J Hugon Journal of cellular and molecular medicine 12 (6b), 2525-2532, 2008	214	2008
Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2α pathway F Mouton-Liger, C Paquet, J Dumurgier, C Bouras, L Pradier, F Gray, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1822 (6), 885-896, 2012	202	2012
Involvement of double‐stranded RNA‐dependent protein kinase and phosphorylation of eukaryotic initiation factor‐2α in neuronal degeneration RCC Chang, KC Suen, CH Ma, W Elyaman, HK Ng, J Hugon Journal of neurochemistry 83 (5), 1215-1225, 2002	194	2002
Contribution to Alzheimer's disease risk of rare variants in TREM2, SORL1, and ABCA7 in 1779 cases and 1273 controls C Bellenguez, C Charbonnier, B Grenier-Boley, O Quenez, K Le Guennec, ... Neurobiology of aging 59, 220. e1-220. e9, 2017	179	2017
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer’s disease A Öhrfelt, A Brinkmalm, J Dumurgier, G Brinkmalm, O Hansson, ... Alzheimer's research & therapy 8, 1-10, 2016	176	2016
Tick‐bite meningoradiculoneuritis: clinical, electrophysiologic, and histologic findings in 10 cases JM Vallat, J Hugon, M Lubeau, MJ Leboutet, M Dumas, ... Neurology 37 (5), 749-749, 1987	168	1987
Tyk2/STAT3 signaling mediates β-amyloid-induced neuronal cell death: implications in Alzheimer's disease J Wan, AKY Fu, FCF Ip, HK Ng, J Hugon, G Page, JH Wang, KO Lai, Z Wu, ... Journal of neuroscience 30 (20), 6873-6881, 2010	162	2010
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study J Dumurgier, S Schraen, A Gabelle, O Vercruysse, S Bombois, ... Alzheimer's research & therapy 7, 1-9, 2015	159	2015

Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.

Articles 1–20

Nombre de citations par an

Citations en double

Citations fusionnées

Ajouter les coauteursCoauteurs

Suivre

Citée par

Coauteurs